Merck Outlines Vioxx Defense

Merck Outlines Vioxx Defense At its annual meeting, Merck discussed its planned defense against the flood of lawsuits brought on by the withdrawal of Vioxx, an arthritis pill taken at one time or another by 20 million Americans.

Survey Shows Lack of Confidence at FDA

Survey Shows Lack of Confidence at FDA About two-thirds of Food and Drug Administration scientists are less than fully confident in the agency’s monitoring of the safety of prescription drugs now being sold, according to an FDA internal survey.

Get email updates

Get new actionable insights and updates from BiotechBlog